UCA1 and chronic myelogenous leukemia, BCR-ABL1 positive: In chronic myeloid leukemia (CML) K562 cells, the upregulation of lncRNA UCA1 was shown to increase the MDR transporter ABCB1 expression and induce resistance to the ABCB1 substrate imatinib[27].